Christina Schmidt, APRN
Adult Health · Overland Park, KSNPI 1609112838
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $869 of the $968 with a category attached, or 89.8%. It is spread thinly across 16 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $436, 4.0 times the $110 reported in 2022.
Across 33 payments — averaging $29.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$138
- Genentech, Inc.$130
- AbbVie$112
- Johnson & Johnson$94
- Puma Biotechnology, Inc.$89
- AstraZeneca$75
- plus $330 from 10 others
What the payments were for
- Food & beverage$86990%
- Education$9910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 3 | $138 |
| Genentech, Inc. | 2 | $130 |
| AbbVie | 4 | $112 |
| Johnson & Johnson | 2 | $94 |
| Puma Biotechnology, Inc. | 1 | $89 |
| AstraZeneca | 3 | $75 |
| Merck | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Novartis | 3 | $51 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Urogen Pharma, Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| GSK | 1 | $16 |
| Calyxo, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
How this compares
$968 in reported general payments places this provider in the 60th percentile of 155 adult health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 40 | $610,913 |
| VerzenioAbemaciclib | 37 | $550,410 |
| KisqaliRibociclib Succinate | 19 | $283,689 |
| ImbruvicaIbrutinib | 19 | $264,840 |
| BrukinsaZanubrutinib | 18 | $207,743 |
| VenclextaVenetoclax | 15 | $194,628 |
| Abiraterone Acetate | 13 | $7,785 |
| Letrozole | 26 | $1,171 |
| Ondansetron Hcl | 38 | $794 |
| Dexamethasone | 42 | $534 |
| Hydroxyurea | 14 | $398 |
| Ondansetron OdtOndansetron | 30 | $356 |
| Gabapentin | 12 | $297 |
| Prochlorperazine Maleate | 26 | $260 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisKisqali | $51 | $283,68919 claims |
| AbbVieVenclexta | $112 | $194,62815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 155 adult health providers in Kansas.
Other adult health in Overland Park
- Lauren FieldsOverland Park$12K
- Tina LegaultOverland Park$12K
- Monica PfeifferOverland Park$7K
- Amy RiederOverland Park$6K
- Paige BudzinskiOverland Park$4K
- Mary MartinOverland Park$2K
- Carla ShepardOverland Park$2K
- Jill SoenenOverland Park$1K
- Carrie EnglertOverland Park$1K
- Debra MorrisOverland Park$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.